Preparation and characterization of PLGA particles for subcutaneous controlled drug release by membrane emulsification.
Uniformly sized microparticles of poly(D,L-lactic-co-glycolic) (PLGA) acid, with controllable median diameters within the size range 40-140 microm, were successfully prepared by membrane emulsification of an oil phase injected into an aqueous phase, followed by solvent removal. Initially, simple particles were produced as an oil in water emulsion, where dichloromethane (DCM) and PLGA were the oil phase and water with stabiliser was the continuous phase. The oil was injected into the aqueous phase through an array type microporous membrane, which has very regular pores equally spaced apart, and two different pore sizes were used: 20 and 40 microm in diameter. Shear was provided at the membrane surface, causing the drops to detach, by a simple paddle stirrer rotating above the membrane. Further tests involved the production of a primary water in oil emulsion, using a mechanical homogeniser, which was then subsequently injected into a water phase through the microporous membrane to form a water in oil in water emulsion. These tests used a water-soluble model drug (blue dextran) and encapsulation efficiencies of up to 100% were obtained for concentrations of 15% PLGA dissolved in the DCM and injected through a 40 microm membrane. Solidification of the PLGA particles was followed by removal of the DCM through the surrounding aqueous continuous phase. Different PLGA concentrations, particle size and osmotic pressures were considered in order to find their effect on encapsulation efficiency. Osmotic pressure was varied by changing the salt concentration in the external aqueous phase whilst maintaining a constant internal aqueous phase salt concentration. Osmotic pressure was found to be a significant factor on the resulting particle structure, for the tests conducted at lower PLGA concentrations (10% and 5% PLGA). The PLGA concentration and particle size distribution influence the time to complete the solidification stage and a slow solidification, formed by stirring gently overnight, provided the most monosized particles and highest encapsulation efficiency.
Gasparini
G
G
Department of Chemical Engineering, Loughborough University, Leicestershire LE11 3TU, UK.
Kosvintsev
S R
SR
Stillwell
M T
MT
Holdich
R G
RG
D000279:Administration, Cutaneous; D003692:Delayed-Action Preparations / Q000138:chemical synthesis* / Q000737:chemistry*; D004655:Emulsions / Q000737:chemistry*; D019344:Lactic Acid / Q000138:chemical synthesis* / Q000737:chemistry*; D008567:Membranes, Artificial; D008863:Microspheres; D010316:Particle Size; D011100:Polyglycolic Acid / Q000138:chemical synthesis* / Q000737:chemistry*; D000077182:Polylactic Acid-Polyglycolic Acid Copolymer; D011108:Polymers / Q000138:chemical synthesis* / Q000737:chemistry*; D012492:Salts / Q000494:pharmacology; D014867:Water
D003692:Delayed-Action Preparations; D004655:Emulsions; D008567:Membranes, Artificial; D011108:Polymers; D012492:Salts; D014867:Water; D000077182:Polylactic Acid-Polyglycolic Acid Copolymer; D011100:Polyglycolic Acid; D019344:Lactic Acid